Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial

AIMS/HYPOTHESIS: There are limited data comparing dipeptidyl peptidase-4 (DPP-4) inhibitors directly. We compared the safety and efficacy of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment (RI). METHODS: This study was a parallel-arm, randomised, multicentre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kothny, Wolfgang, Lukashevich, Valentina, Foley, James E., Rendell, Marc S., Schweizer, Anja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526592/
https://www.ncbi.nlm.nih.gov/pubmed/26067186
http://dx.doi.org/10.1007/s00125-015-3655-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526592/
https://www.ncbi.nlm.nih.gov/pubmed/26067186
http://dx.doi.org/10.1007/s00125-015-3655-z

Ejemplares similares